History of immunotherapy: the first 100 years
- PMID: 21530811
- DOI: 10.1016/j.iac.2011.03.003
History of immunotherapy: the first 100 years
Abstract
Allergen-specific immunotherapy (SIT) defines and distinguishes the modern practice of clinical allergy and immunology as the 100th anniversary of this pioneering technique is celebrated. Despite the tremendous advancements made in therapeutics, pharmacology, and the basic science of allergy, SIT remains the only treatment modality that offers a potential cure for atopic diseases rather than simply an amelioration of symptoms. A historical perspective not only offers an opportunity to tell some of the fascinating stories that led to the conception of SIT but also gives an occasion to recognize, remember, and honor those individuals who have contributed to its development.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Allergen immunotherapy: a history of the first 100 years.Curr Opin Allergy Clin Immunol. 2011 Dec;11(6):554-9. doi: 10.1097/ACI.0b013e32834c3134. Curr Opin Allergy Clin Immunol. 2011. PMID: 21971334 Review.
-
Hundred years of allergen immunotherapy.Clin Exp Allergy. 2011 Sep;41(9):1221-5. doi: 10.1111/j.1365-2222.2011.03768.x. Epub 2011 May 10. Clin Exp Allergy. 2011. PMID: 21554436
-
Allergen immunotherapy in historical perspective.Clin Allergy Immunol. 2008;21:1-29. Clin Allergy Immunol. 2008. PMID: 18828495 Review. No abstract available.
-
Some highlights of the first century of immunotherapy.Ann Allergy Asthma Immunol. 2011 Nov;107(5):417-21. doi: 10.1016/j.anai.2011.05.013. Epub 2011 Jun 29. Ann Allergy Asthma Immunol. 2011. PMID: 22018612 Review. No abstract available.
-
100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT).Allergy. 2011 Jun;66(6):713-24. doi: 10.1111/j.1398-9995.2010.02541.x. Epub 2011 Feb 15. Allergy. 2011. PMID: 21320133
Cited by
-
Nanotechnology-Based Vaccines for Allergen-Specific Immunotherapy: Potentials and Challenges of Conventional and Novel Adjuvants under Research.Vaccines (Basel). 2020 May 20;8(2):237. doi: 10.3390/vaccines8020237. Vaccines (Basel). 2020. PMID: 32443671 Free PMC article. Review.
-
Exploiting metabolic glycoengineering to advance healthcare.Nat Rev Chem. 2019 Oct;3(10):605-620. doi: 10.1038/s41570-019-0126-y. Epub 2019 Sep 6. Nat Rev Chem. 2019. PMID: 31777760 Free PMC article.
-
The Relationship Between Eosinophilic Esophagitis and Immunotherapy.Immunol Allergy Clin North Am. 2024 May;44(2):281-291. doi: 10.1016/j.iac.2024.01.001. Epub 2024 Feb 14. Immunol Allergy Clin North Am. 2024. PMID: 38575223 Free PMC article. Review.
-
Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy.Pharmaceutics. 2020 Aug 11;12(8):758. doi: 10.3390/pharmaceutics12080758. Pharmaceutics. 2020. PMID: 32796670 Free PMC article. Review.
-
Improving Immunotherapy Through Glycodesign.Front Immunol. 2018 Nov 2;9:2485. doi: 10.3389/fimmu.2018.02485. eCollection 2018. Front Immunol. 2018. PMID: 30450094 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical